Trial Profile
Long-term evaluation of efficacy and safety of levetiracetam in routine clinical practice in the Czech and Slovak Republics, Hungary, and Romania - Non-interventional study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Oct 2014
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Myoclonic epilepsies; Partial epilepsies
- Focus Therapeutic Use
- Sponsors UCB
- 17 Dec 2009 Actual end date (June 2009) added as reported by ClinicalTrials.gov record.
- 17 Dec 2009 Actual number of patients (2569) added as reported by ClinicalTrials.gov record.
- 17 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.